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Nuclear egress of herpesvirus capsids through the nuclear envelope is mediated by the
multimeric nuclear egress complex (NEC). The human cytomegalovirus (HCMV) core NEC is
defined by an interaction between the membrane-anchored pUL50 and its nuclear co-factor
pUL53, tightly associated through heterodimeric corecruitment to the nuclear envelope.
Cellular proteins, such as p32/gC1qR, emerin and protein kinase C (PKC), are recruited by
direct interaction with pUL50 for the multimeric extension of the NEC. As a functionally
important event, the recruitment of both viral and cellular protein kinases leads to site-specific
lamin phosphorylation and nuclear lamina disassembly. In this study, interaction domains within
pUL50 for its binding partners were defined by co-immunoprecipitation. The interaction
domain for pUL53 is located within the pUL50 N-terminus (residues 10–169), interaction
domains for p32/gC1qR (100–358) and PKC (100–280) overlap in the central part of
pUL50, and the interaction domain for emerin is located in the C-terminus (265–397).
Moreover, expression and formation of core NEC proteins at the nuclear rim were
consistently detected in cells permissive for productive HCMV replication, including two
trophoblast-cell lines. Importantly, regular nuclear-rim formation of the core NEC was blocked
by inhibition of cyclin-dependent kinase (CDK) activity. In relation to the recently published
crystal structure of the HCMV core NEC, our findings result in a refined view of NEC
assembly. In particular, we suggest that CDKs may play an important regulatory role in NEC
formation during HCMV replication.
INTRODUCTION
Human cytomegalovirus (HCMV) is a globally human patho-
gen that infects immunocompetent individuals mostly without
producing overt symptoms, whereas it is a major cause of
morbidity and fatal disease in immunocompromised patients.
Moreover, HCMV is the leading non-genetic cause of congeni-
tal malformation in developed countries. HCMV infection
causes serious sequelae in immunocompromised patients and
the developing foetus during pregnancy (Hamilton et al.,
2014). HCMV seroprevalence ranges from 40% in highly
industrialized areas to 90% in developing countries (Adler
et al., 2007; Mocarski et al., 2013). In general, HCMV and
other herpesviruses undergo a cascade-like regulated replica-
tion, which is initiated in the host cell nucleus (Ogawa-Goto
et al., 2003). Thereafter, preformed viral capsids, packaged
with genomic DNA, have to be translocated into the cyto-
plasm. Due to their large size (~130nm), HCMV capsids are
not able to pass the nuclear pore complex and a widely
accepted mechanism for nuclear egress is considered by which
viral capsids bud through nuclear membranes (Johnson &
Baines, 2011; Mettenleiter et al., 2013). To gain access to the
inner nuclear membrane (INM), capsids need to traverse the
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1676 000495 ã 2016 The Authors Printed in Great Britain
Journal of General Virology (2016), 97, 1676–1685 DOI 10.1099/jgv.0.000495
Downloaded from www.microbiologyresearch.org by
IP:  161.53.41.203
On: Wed, 07 Nov 2018 09:33:02
nuclear lamina, which underlies the INM. The nuclear lamina
comprises a dense meshwork of nuclear lamins and lamina-
associated proteins, and represents a natural barrier for viral
nuclear egress. Thus, the nuclear lamina needs to be disas-
sembled during herpesviral replication by the action of a viral–
cellular multimeric-protein complex, termed nuclear egress
complex (NEC) (Milbradt et al., 2009). The recruitment of
protein kinases to the NEC leads to the phosphorylation of
lamins and thereby to a partial disassembly of the nuclear lam-
ina. Notably, the core of the HCMV-specific NEC is formed
by two conserved viral proteins, pUL50 and pUL53. The inte-
gral membrane protein pUL50 is associated with the INM by
its transmembrane domain, whereas the nuclear phosphopro-
tein pUL53 carries a classical nuclear localization signal (NLS,
aa 18–27) (Schmeiser et al., 2013) and accumulates in a
nuclear rim localization upon interaction with the INM-asso-
ciated pUL50. A currently accepted concept is that pUL50 and
pUL53, as well as their a-, b- and g-herpesviral homologues,
are functionally essential for nuclear capsid egress, with the
exception of distinct alphaherpesviral mutants reinforcing an
alternative egress pathway based on nuclear envelope break-
down (Klupp et al., 2011; Grimm et al., 2012). Once the core
NEC is formed, further NEC proteins like p32/gC1qR, emerin
and additional candidates are recruited (Milbradt et al., 2014).
Among these, viral protein kinase pUL97, cellular protein
kinase C isoform a (PKCa) and possibly others are recruited
(Milbradt et al., 2007, 2009) in order to phosphorylate nuclear
lamins resulting in lamina disassembly (Hamirally et al., 2009;
Milbradt et al., 2010). The recently solved crystal structure of
the pUL50-pUL53 complex suggests that pUL50-pUL53
heterodimers assemble to hexameric ring-like structures, act-
ing as a scaffold for binding of further NEC proteins (Walzer
et al., 2015). Hence, the NEC represents an attractive and
promising target for antiviral drug development. It has been
shown previously that inhibition of pUL97 activity, in particu-
lar pUL97-mediated core NEC phosphorylation, led to a sig-
nificant reduction of viral titres, underlining the importance of
proper NEC formation (Prichard et al., 1999; Wolf et al.,
2001; Krosky et al., 2003; Marschall et al., 2005; Sharma et al.,
2015).
In this study, we provide a closer insight into the
HCMV-specific NEC formation. By performing
co-immunoprecipitation (CoIP) experiments, we identified
four partly distinct, partly overlapping pUL50-interaction
domains being necessary and sufficient for interaction with
the NEC components pUL53, p32/gC1qR, emerin and
PKCa. Expression of pUL50-pUL53 and core NEC forma-
tion was demonstrated in human cell types comprising vari-
able levels of HCMV permissiveness, also including
trophoblast cell lines. In addition, nucleoplasmic relocaliza-
tion of pUL53 from the nuclear rim was demonstrated
upon inhibition of cellular cyclin-dependent kinase (CDK)
activity in HCMV-infected and plasmid-transfected cells.
Combined, our data support an extended model of NEC
formation, primarily based on four interaction domains in
pUL50, also including the relevance of cell type, cellular
pUL50-associated NEC proteins and cellular kinase activity.
RESULTS
Expression pattern of core NEC proteins and
nuclear rim formation is a common feature
among HCMV-permissive cells, but shows
variation in poorly permissve cell types
Coordinated NEC formation is a crucial step in HCMV rep-
lication. Initially, pUL50 is produced with early-phase
kinetics, translocated into the nucleus, and accumulates at
the INM to recruit other cellular and viral components
involved in nuclear lamina reorganization (Hamirally et al.,
2009; Milbradt et al., 2010; Schmeiser et al., 2013). We
addressed the question of whether NEC formation may
vary between different host cell types being HCMV-permis-
sive (HFF, MRC-5), semi-permissive (U373, TEV-1) or
non-permissive for productive replication in cell culture
(293T). Experiments were performed using HCMV strain
AD169 at a multiplicity of infection (MOI) of 1. Three days
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Fig. 1. Nuclear rim localization of the core NEC in HCMV-permis-
sive and -non-permissive cell types. Infection of (a) 293T, U373,
HFF, MRC-5 and (b) TEV-1 cells with HCMV strain AD169 at a
MOI of 1. At 3 dpi, cells were fixed and co-immunostained with
antibodies directed against HCMV immediate-early proteins 1 and
2 (IE1/IE2) or pUL53 as indicated. Nuclei were counterstained by
DAPI (4,6-diamidino-2-phenylindole). Samples were analysed by
confocal microscopy.
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post-infection (dpi), intracellular pUL53 localization was
compared to that of viral immediate-early proteins (IE1 and
IE2) by confocal microscopy (Fig. 1). All cell types used
showed IE1/IE2 expression, indicating consistently success-
ful viral entry and onset of viral gene expression (Fig. 1a)
(notably, regular IE1/IE2 expression in HCMV-infected
TEV-1 cells was detected in a control experiment, data not
shown). Moreover, pUL53 was detected in U373, HFF,
MRC-5 (Fig. 1a) and TEV-1 cells (Fig. 1b). On the contrary,
293T cells were negative for pUL53, indicating that viral
replication is impeded in this cell type (confirming earlier
data by Ellsmore et al., 2003).
In a following step, we performed Western blot kinetic
experiments to monitor the presence of pUL50 and pUL53
along the course of infection (Fig. 2). At consecutive time
points, IE1 production was detectable starting from 1 dpi in
all cell types analysed (Fig. 2a). This also included 293T cells
in which, however, later viral proteins were missing. Nota-
bly, the semi-permissive U373 cells expressed only marginal
levels of pUL50 and pUL53 at a delayed kinetic (Fig. 2a,
lanes 9 10). In comparison, the placental cell line TEV-1
showed a stronger level of core NEC expression at late time
points of infection (lanes 14 15). Interestingly, the infec-
tion rate of TEV-1 cells also varied between different
HCMV strains, indicated by variable expression patterns of
viral IE, early (E) and late (L) proteins (Fig. 2a). Another
placental cell line, JEG3, showed a variable expression of E
proteins (i.e. reduced levels of pUL44; pUL50 and pUL53
expression was under the detection limit) upon infection
with HCMV strain AD169 (propagated in HFFs). More-
over, JEG3 cells completely lacked expression of the L major
capsid protein (MCP) (Fig. 2c). In contrast, HCMV pro-
teins were consistently and strongly expressed in HFF and
MRC-5 fibroblasts at 3 dpi (Fig. 2a, lanes 16–25). Thus, our
findings indicate that the expression of core NEC proteins
and nuclear rim formation is conserved in cells permissive
for productive HCMV replication.
Core NEC formation is sensitive to inhibitors of
CDK activity
As demonstrated in detail by previous confocal imaging
analyses (Milbradt et al., 2012; Schmeiser et al., 2013;
Sharma et al., 2015), pUL50 and pUL53 recruit each other
into a nuclear rim-associated NEC structure. Notably, this
rim colocalization is blocked by treatment with the pUL97-
specific inhibitor maribavir (MBV) (Sharma et al., 2015). In
this study, we looked at whether or not inhibitors of cellular
kinases similarly block core NEC formation at the nuclear
rim. CDK inhibitors were suspected as candidates, since
CDKs and pUL97 are considered as orthologues, sharing
properties of cyclin binding, substrate phosphorylation and
regulatory functions in HCMV replication (Hume et al.,
2008; Graf et al., 2013; Steingruber et al., 2015). For this
purpose, we infected HFFs with the recombinant HCMV
AD169-GFP UL50-HA expressing the green fluorescent
protein (GFP) as a marker of infected cells and pUL50 fused
to an HA-tag. Infected cells were cultivated in the presence
or absence of the CDK inhibitors R25 (also known as
Alsterpaullone), R22 or LDC4297 (Fig. 3a). Control cells
(DMSO, dimethyl sulfoxide) and cells treated with the
CDK9-specific inhibitor R22 or CDK7-specific inhibitor
LDC4297 displayed regular rim co-localization of pUL50
with pUL53 (Fig. 3a, panels a–d and i–q). Notably, z-series
of corresponding areas revealed that some cells showed co-
localization of pUL50 and pUL53 in tubular structures
spanning the nucleus from the bottom to the top (e.g. open
arrows in xz and yz sections of Fig. 3a, panels d, m and q).
These tubular structures are common in human fibroblasts
and represent transnuclear channels of nuclear membrane
invaginations which allow transport between different cyto-
plasmic regions (Broers et al., 2006). Intriguingly, we addi-
tionally observed intranuclear aggregates of pUL50-pUL53
co-localization under R25 treatment (Fig. 3a, panels e–h),
but not under treatment with R22 or LDC4297 (panels i–
q). In contrast to the nucleus-spanning tubules, these are
distinct aggregates adjacent to the nuclear rim but not con-
tinuous with the nuclear membrane (see yellow-filled arrows
in xz and yz sections of Fig. 3a, panel h). This R25-mediated
phenotype was specifically pronounced for pUL53. Interest-
ingly, treatment with the pUL97 inhibitor MBV resulted in
similar intranuclear aggregates of pUL50 and pUL53
(Fig. 3a, panels r–u). Notably, R25 has activity against
CDKs including CDK1, CDK2 and CDK5 (Sandal et al.,
2002; Soni & Jacobberger, 2004), but it does not block
pUL97-mediated substrate phosphorylation (Sonntag, E.,
Marschall, M. & Milbradt, J., unpublished data).
To verify that the observed effect in R25-treated cells is inde-
pendent of the viral protein kinase pUL97, we studied pUL50
and pUL53 localization in transfected HeLa cells (Fig. 3b). As
expected, MBV treatment had no effect on the nuclear rim co-
localization of pUL50 and pUL53 compared with DMSO-
treated control cells in the absence of pUL97 or other
viral proteins (Fig. 3b, panels a–d and r–u). However, the addi-
tion of R25 changed the nuclear rim localization of pUL50 and
pUL53 also in transfected cells. In particular, R25 treatment
induced intranuclear aggregates of pUL53 and pUL50 adjacent
to the nuclear rim in 61.9% of investigated cells (Fig. 3b, pan-
els e–h). Similar to HCMV infection, the effect of R25 in trans-
fected cells was more pronounced for pUL53. Moreover,
LDC4297 treatment also induced re-localization of pUL50 and
pUL53 in transfected cells, albeit at lower efficacy (Fig. 3b, pan-
els i–m). In contrast, treatment with R22 did not induce simi-
lar changes so that core NEC proteins remained in their
original nuclear rim co-localization (Fig. 3b, panels n–q).
In a next step, we performed co-immunoprecipitation
(CoIP) analysis to establish whether or not specific CDKs
are directly associated with the viral core NEC. Importantly,
pUL50 was able to co-immunoprecipitate CDK1 from
lysates of transiently transfected 293T cells (Fig.
S1, available with the online supplementary material). The
detectability of CDK1-pUL50 interaction, however, varied
between individual experiments and the functional impor-
tance of this interaction remains to be clarified. As seen
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from the current state of analysis, both results derived from
the CoIP and the confocal kinase inhibitor studies suggest
the involvement of CDKs in core NEC formation. Taken
together, our findings provide the first evidence that
core NEC formation is sensitive to CDK inhibitors and may
thus be directly dependent on CDK activity.
Localization of individual constituents of the
multimeric NEC is differentially sensitive to the
CDK inhibitor R25
The core NEC recruits further proteins to form a multi-
meric NEC at the late stages of HCMV replication (Mil-
bradt et al., 2014). Thus, we investigated the effect of R25
on the subcellular localization of further components of
the multimeric NEC, namely p32/gC1qR (Fig. 3c) and
emerin (Fig. 3d). p32/gC1qR is a predominant mitochon-
drial protein that can accumulate in the nucleus under
specific stimuli (Brokstad et al., 2001). Notably, p32/gC1qR
localization changed from a tubular cytoplasmic localization
in uninfected cells (mock) to a partial translocation into
the nucleus during HCMV replication (Fig. 3c, compare
panels i–m to panels a–d), confirming previous results
(Milbradt et al., 2014). Intriguingly, inhibition of CDK
activity by R25 treatment decreased the nuclear abundance
of p32/gC1qR but led to a partial co-localization with
pUL53 in the inhibitor-induced intranuclear aggregates
(Fig. 3c, panels e–h). However, R25 treatment showed the
reciprocal phenotype of an increased nuclear translocation
in uninfected cells compared to DMSO treatment (Fig. 3c;
compare panels n–q to panels i–m). This finding was
unexpected and pointed to a complex regulation of NEC
constituents by cellular and viral protein kinases. In con-
trast to p32/gC1qR, emerin did not show similarly altered
localization following R25 treatment (Fig. 3d). In conclu-
sion, localization of specific NEC constituents is either
directly or indirectly regulated by CDK activity during
HCMV replication. Moreover, it appears highly likely that
multiple events of phosphorylation are required for proper
formation of the multimeric NEC.
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Fig. 2. Viral protein expression in cell types differentially permissive for HCMV. Various cell types were infected with HCMV
strain AD169 at a MOI of 1 (a), at a MOI of 10 (c), or were infected with HCMV strains Towne, TB40E and Merlin at a MOI of
1 (b) as indicated. Cells were harvested and lysed at consecutive time points post-infection, shown above blots. Expression
levels of IE1 (splice variant IE1p72), early (pUL44, pUL50, pUL53) and late proteins (MCP) were analysed by Western blot
analyses using protein-specific antibodies.
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Fig. 3. Effect of CDK inhibitors on NEC formation. (a,c,d) HFFs were infected with recombinant HCMV AD169-GFP UL50-
HA at a MOI of 1 or remained uninfected (mock). (b) HeLa cells were transiently co-transfected with plasmids coding for HA-
tagged pUL50 or FLAG-tagged pUL53. (a-d) The protein kinase inhibitors R25 (3 m), R22 (3 µm), LDC4297 (0.5 µm), mari-
bavir (MBV, 5 µm) or DMSO were added to infected cells at 74 and 94 h post-infection (hpi) (a,c,d) and to transfected cells
directly after plasmid transfection (b). Infected and transfected cells were fixed at 96 hpi (a,c,d) and 48 h post-transfection (b),
respectively, and subjected to indirect immunofluorescence analysis using protein- or tag-specific antibodies. The subcellular
localization of viral pUL50 and pUL53, as well as cellular p32/gC1qR and emerin, was detected by recording confocal z-series.
Representative images of a single focal plane (xy) are depicted for individual stainings. In addition, xz and yz axes are depicted
for merged images. White dotted lines and black arrowheads, optical section through the z stack (xy) or the focal plane (xz
and yz); yellow-filled arrows,intranuclear aggregates of pUL50/pUL53 co-localization; yellow open arrows, transnuclear trans-
port channels common in fibroblasts.
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Functional map of pUL50 regions determining its
binding to pUL53, PKCa, p32/gC1qR and emerin
Various lines of experimental evidence suggested that the
cytomegaloviral core NEC acts as a scaffold to assemble
accessory NEC components (Muranyi et al., 2002; Milbradt
et al., 2007, 2009, 2014; Buchkovich et al., 2010; Lemnitzer
et al., 2013). In particular, pUL50 defines the formation of
the multimeric NEC by interacting with pUL53, PKCa,
p32/gC1qR and emerin. Previously, we used either N- or C-
terminally truncated versions of pUL50 to determine the
interaction domains facilitating its multiple interactions
(Milbradt et al., 2009, 2014). In this study, we generated
expression constructs coding for specific regions of pUL50
and analysed these in respect of their binding characteristics
by CoIP assay (Fig. 4a–d). Specifically, residues 10–169 of
pUL50 were sufficient for pUL53 CoIP (Fig. 4a, lane 4),
whereby the quantity of interaction signals was reduced in
comparison to the full-length protein (Fig. 4a, compare lane
3 with lane 4). The specificity of CoIP reactions was assured
by the use of an Fc fragment as control (Fig. 4a, lane 1). For
interaction with PKCa and p32/gC1qR, responsible regions
of pUL50 were mapped to partly overlapping interaction
domains comprising residues 100–280 (Fig. 4b, lanes 2 and
3) and residues 100–358 (Fig. 4c, lanes 2 and 3), respec-
tively. Distinct from these interaction domains, the region
responsible for emerin interaction was mapped to the C-ter-
minus of pUL50 (Fig. S2). In particular, residues 265–397 of
pUL50 were sufficient to confer emerin interaction (Fig. 4d,
lanes 3 and 4), whereby C-terminal truncation abolished
interaction (Fig. S2, lanes 9–11). The resulting interaction
domains were evaluated as specific, since we did not observe
cross-interaction with emerin (Fig. 4a–c, lane 3 or 4) or
PKCa (Fig. 4d, lane 4). Staining of lysate controls demon-
strated comparable levels of transiently expressed proteins
(Fig. 4a–d, lower panels). A summary of CoIP data is pre-
sented schematically (Fig. 5a), illustrating the partly over-
lapping pUL50 interaction domains for pUL53, PKCa, p32/
gC1qR and emerin. It should be stressed that Fig. 5b shows
a partial inset of the recently resolved crystal structure of the
pUL50-pUL53 heterodimeric complex (Walzer et al., 2015).
Residues 10–169 of pUL50, representing the minimal inter-
action domain for pUL53, are displayed in green; residues
50–84 of pUL53 forming an N-terminal hook-like extension
determining interaction in red. Primary and secondary
structural features of pUL50 are depicted in Fig. 5c. Intrigu-
ingly, for the C-terminal part of pUL50 stretching outside
the globular domain (comprising residues 1–209) (Milbradt
et al., 2012), only a few secondary structural elements were
predicted, so that this disordered region appears to be
mostly unstructured. This is even more remarkable consid-
ering the finding that the main part of the three overlapping
interaction domains for PKCa, p32/gC1qR and emerin is
almost entirely contained within the C-terminal half of the
protein (Fig. 5c). Combined, this structural and functional
arrangement of four interaction domains spanning pUL50
is a highly interesting feature that has not been recognized
to date. Thus, the unique assembly properties of pUL50
may define its central role in scaffolding multimeric interac-
tions of viral and cellular proteins within the cytomegalovi-
rus-specific NEC.
DISCUSSION
In this study, we provide novel insights into the assembly of
the HCMV-specific multimeric NEC and the defining role
of the core NEC constituent pUL50. We used biochemical
methods including CoIP analyses and confocal microscopy
to explore the recruitment and interaction of NEC compo-
nents in various host cell types and a potential role of cellu-
lar CDKs for efficient NEC formation. The main findings
are: (i) the core NEC is formed in HCMV-permissive host
cells; (ii) treatment with CDK inhibitors impairs efficient
core NEC formation in HCMV-infected cells; and (iii)
pUL50 defines the assembly of the multimeric NEC by
partly distinct and partly overlapping interaction domains
for accessory NEC components.
Assembly of the core NEC is characterized by an interac-
tion-driven recruitment of pUL50 and pUL53, resulting in
their perfect co-localization at the nuclear envelope of
HCMV-infected cells (Schmeiser et al., 2013, 2015). Here,
we investigated nuclear rim formation of pUL53 in various
cell types which are differentially permissive for HCMV
infection. In semi-permissive (U373, TEV-1) and fully per-
missive cells (HFF, MRC-5), pUL53 is perfectly localized at
the nuclear rim. In line with our Western blot results, reli-
able levels of expression of the two core NEC proteins were
detected in these cells by confocal microscopy. Interestingly,
expression of pUL50 and pUL53 was also detected in tro-
phoblast cells, but TEV-1 and JEG3 cells showed slight dif-
ferences in expression patterns of both proteins during
infection. A possible reason for this is that TEV-1 and JEG3
cells differ in their developmental stages (i.e. transformed
extra-villious first-trimester cells or choriocarcinoma cells,
respectively). Moreover, confocal microscopy demonstrates
rim staining of pUL53 in HCMV-infected cells, indicating
core NEC formation also in trophoblast cells. On the con-
trary, 293T cells are known to be non-permissive for the
production of infectious HCMV. Nevertheless, we detected
viral IE protein expression following HCMV infection,
while expression of E proteins, including pUL50 and
pUL53, and L proteins was missing. This confirms earlier
findings, illustrating that the viral replication cycle is
impeded in 293T cells and the course of infection is abortive
(Ellsmore et al., 2003). In addition to the cell type-specific
differences in core NEC expression, we also demonstrated
that the time course of NEC formation is dependent on
HCMV strains (Dolan et al., 2004). Notably, our data exem-
plify that the onset of expression of core NEC proteins in
TEV-1 cells slightly differed between the HCMV strains
analysed. Thus, our findings indicate that nuclear rim for-
mation and expression of core NEC proteins show some
degree of cell type- and viral strain-specific variation, but
are conserved for cells permissive for productive HCMV
infection.
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Regular NEC formation is dependent on pUL50-pUL53
heterodimerization (Milbradt et al., 2012; Sam et al., 2009;
Walzer et al., 2015) and post-translational protein modifica-
tion (Sharma et al., 2015). Phosphorylation of pUL50 and
pUL53 by the HCMV-encoded protein kinase pUL97 is
essential for proper nuclear rim localization. In particular,
Sharma and colleagues demonstrated that an inhibitor-
mediated block of pUL97 results in a significant reduction
in viral titres and, moreover, leads to a punctate distribution
of both pUL50 and pUL53 (Sharma et al., 2015). Recent
reports from our group suggested functionally relevant
cyclin interaction of the viral kinase pUL97 (Graf et al.,
2013; Steingruber et al., 2015), further substantiating the
role of pUL97 as a viral CDK ortholog (Hume et al., 2008).
Besides HCMV pUL97, regulation of NEC formation and
function by cellular kinases has been discussed in various
aspects (Marschall et al., 2011). On the one hand, a func-
tional role of cellular PKCa in the virus-mediated nuclear
lamina disassembly during infection with HCMV and other
herpesviruses has been suggested (Muranyi et al., 2002,
2009, 2010; Leach & Roller, 2010). Moreover, PKCa phos-
phorylates pUL50 in vitro (Milbradt et al., 2007 ). On the
other hand, it is tempting to speculate that cellular CDKs
additionally regulate the NEC. Previous studies
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demonstrated the general importance of CDK activity for
efficient HCMV replication (Schang et al., 2005; Sanchez &
Spector, 2006; Hertel et al., 2007). To address whether or
not CDKs regulate core NEC formation, we blocked CDK
activity by treatment of HCMV-infected cells with known
CDK inhibitors. Importantly, pUL53 and pUL50 were par-
tially re-localized from their nuclear rim localization into
the nucleoplasm of HCMV-infected cells following treat-
ment with 3 µm of the CDK inhibitor R25 (i.e. R25 blocks
activity of CDK1, CDK2 and CDK5) (Sandal et al., 2002;
Soni & Jacobberger, 2004). Consistent with our data, R25
treatment has been shown to reduce viral titres by approxi-
mately 1.2 log units, even at a much lower dose of 150 nM
(Bigley et al., 2015). The identification of the CDK1-pUL50
interaction by CoIP analysis in the present study further
suggests that at least CDK1 is directly involved in core NEC
formation. Hertel and colleagues previously showed that
inactivation of CDK1 alone is not sufficient to reduce viral
titres, but a broader set of CDK activities is important for
efficient progression of HCMV replication (Hertel et al.,
2007). Thus, our data suggest that the concerted action of
cellular CDKs in addition to the viral kinase pUL97 is essen-
tial for regular NEC assembly. In addition to the inhibition
of CDKs, R25 has activity against glycogen synthase kinase
3 (GSK3) isoforms. The potential functional relevance of
GSK3 and Wnt signalling for NEC formation and nuclear
egress remains to be elucidated in future studies.
In general, NEC formation is a tightly regulated multi-step
process which consists of the recruitment of several cellular
and viral proteins. Previously, we identified the most impor-
tant players for the formation of the HCMV-specific multi-
meric NEC: viral core NEC proteins pUL50–pUL53, cellular
targeting and adaptor proteins emerin and p32/gC1qR, as
well as the lamin-phosphorylating protein kinases pUL97
and PKCa (Milbradt et al., 2009, 2014). In the present
study, we elucidated pUL50 regions that are required for
NEC formation. Importantly, the pUL50N-terminus is
essential for pUL53 binding, and thus sufficient for core
NEC formation. In line with this finding, the recently
resolved crystal structure of the pUL50-pUL53 core NEC
demonstrated that this portion of pUL50 actually displays
the central interaction surface for pUL53 (Lye et al., 2015;
Walzer et al., 2015). For PKCa and p32/gC1qR, the interac-
tion domains are partly located within the globular central
part, but extend into the disordered C-terminus of pUL50.
The interaction domain for emerin is completely located
within the disordered C-terminus. Hence, the pUL50 C-ter-
minus emerges as an essential scaffold for the formation of
the multimeric NEC.
In summary, our results suggest that core NEC formation,
on the basis of pUL50-pUL53 heterodimerization and strict
nuclear rim recruitment, is a conserved process in HCMV-
permissive cells. In this regard, the pUL50N-terminus is
sufficient for core NEC formation with pUL53, while cen-
tral and C-terminal parts of pUL50 determine interaction
with further constituents of the HCMV-specific multimeric
NEC. Importantly, inhibitor experiments suggested that
NEC formation is regulated by cellular CDK activity. Taken
together, these findings provide novel insights into NEC
formation during HCMV infection and might be used to
develop novel strategies for future therapeutic intervention.
METHODS
Plasmid constructs. Expression plasmids coding for haemagglutinin
(HA)-tagged truncation mutants of HCMV pUL50 were generated by
PCR amplification of the UL50 open reading frame. N-terminal (i.e.
encoding amino acids 180–397, 217–397 or 265–397) as well as N- and
C-terminal truncation mutants of pUL50 (encoding amino acids 10–
169, 100–280, or 100–358) were generated by cloning of PCR products.
Standard PCR amplification was performed using pcDNA-UL50-HA
(Milbradt et al., 2007) as a template and oligonucleotide primers pur-
chased from Biomers (Ulm, Germany); sequences of oligonucleotides
are given in supplemental Table S1. After cleavage with EcoRI/XhoI,
PCR products were inserted into the eukaryotic expression vector
pcDNA3.1 (Life Technologies). Expression plasmids coding for the fol-
lowing HA- or FLAG (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys)-tagged ver-
sions of HCMV and cellular proteins were described previously: HCMV
proteins pUL53-FLAG, pUL50-HA, pUL50(5–397) and pUL50
(40–397); cellular PKCa-FLAG and p32(50–282) (Milbradt et al., 2007,
2009, 2012).
Cell culture, plasmid transfection and human cytomegalovirus
infection. Human embryonic epithelial kidney (HEK) 293T cells and
neuronal glioblastoma U373-MG cells were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM), containing 10% foetal calf
serum (FCS) and 100 mg ml 1 gentamicin. Primary human foreskin
fibroblasts (HFF), embryonic lung fibroblasts MRC-5 and cervix carci-
noma epithelial HeLa cells were cultivated in minimal essential medium
(MEM) containing 7.5% FCS and 100 mg ml 1 gentamicin. Human
first-trimester extra-villous trophoblast TEV-1 cells and human placen-
tal choriocarcinoma JEG3 cells were cultured in DMEM/F-12+Gluta-
aMAX, supplemented with 10% FCS and 1X PSG (kindly provided by
the laboratory of Prof. William D. Rawlinson, Virology Division, SEALS
Microbiology, Prince of Wales Hospital, Sydney, Australia). Transient
transfection in 293T cells was performed by the use of polyethyleni-
mine–DNA complexes (Sigma-Aldrich) as described previously (Schre-
gel et al., 2007). HeLa cells were transfected using Lipofectamine 2000
(Life technologies) according to the manufacturer’s instructions. HCMV
infection experiments were performed at a MOI of 1.0 (or higher as
indicated for specific experiments) using HCMV strains AD169,
AD169-GFP UL50-HA (Schmeiser et al., 2013), Towne, TB40E and
Merlin. After incubation for 90–120min at 37

C, virus inoculi were
removed and replaced with fresh growth medium.
Protein kinase inhibitors. The drugs used in the present study were
obtained from various sources: the CDK inhibitors R25 (also known as
Alsterpaullone) (Rechter et al., 2009) and R22 (Feichtinger et al., 2011)
were provided by GPC Biotech AG (Martinsried, Germany), the CDK7-
specific inhibitor LDC4297 (Hutterer et al., 2015) was provided by Lead
Discovery Centre GmbH (Dortmund, Germany), and maribavir
(MBV), a specific inhibitor of the HCMV protein kinase pUL97 (Trofe
et al., 2008; Chou et al., 2012), was purchased from Shanghai PI Chemi-
cals Ltd (China). The compounds were dissolved in dimethyl
sulfoxide (DMSO) and stored at  20

C according to the manufac-
turer’s instructions.
Antibodies. Monoclonal (mAb) and polyclonal (pAb) antibodies,
mouse pAb-HA (T501, Signalway Antibody LLC, College Park, MD,
USA), mouse mAb-HA (clone HA-7, Sigma-Aldrich) and mouse mAb-
FLAG (1804, Sigma-Aldrich) were used to detect transiently expressed
HA- or FLAG-tagged proteins. Antibodies against HCMV proteins were
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rabbit pAb-IE1/IE2 (Gebert et al., 1997), mouse pAb-UL53 (kindly pro-
vided by Dr P. Dal Monte, Bologna, Italy), mouse mAb-UL50 (UL50.01;
kindly provided by Prof. S. Jonjic and Dr T. Lenac, University of Rijeka,
Croatia) and mouse mAb-UL44 (kindly provided by Prof. B. Plachter,
University of Mainz, Germany). Additional antibodies against HCMV
IE1p72 and MCP were kindly provided by William Britt (University of
Alabama). Antibodies against cellular proteins were mouse mAb-emerin
(H-12, Santa Cruz Biotech), rabbit pAb-p32 (kindly provided by Prof.
W. C. Russel, St Andrews, UK), mouse mAb-cyclin B1 (D-11, Santa
Cruz Biotech), rabbit pAb-cyclin B1 (H-433, Santa Cruz Biotech), rabbit
pAb-CDK1 (cdc2 p34, C-19, Santa Cruz Biotech) and mouse mAb-b-
actin (AC-15, Sigma-Aldrich). Secondary antibodies were Alexa Fluor
488-/555-conjugated secondary antibodies for indirect immunofluores-
cence (Molecular Probes) and horseradish peroxidase-conjugated anti-
mouse/-rabbit secondary antibodies for Western blot analyses (Dianova,
Hamburg, Germany).
Indirect immunofluorescence assay and confocal laser-
scanning microscopy. HFFs or HeLa cells were seeded on coverslips
for infection or transient transfection experiments. At indicated time
points, cells were fixed and permeabilized following indirect immuno-
fluorescence staining as described previously (Milbradt et al., 2007,
2009). Images were acquired using a TCS SP5 confocal laser-scanning
microscope (Leica Microsystems, Wetzlar, Germany). For three-dimen-
sional images, z-series were recorded along 12 µm (z-axis) with a pin-
hole of 1 airy unit. Images and z-series were analysed using LAS AF
software (Leica Microsystems, Wetzlar, Germany).
Co-immunoprecipitation (CoIP) assay. 293T cells were seeded into
10 cm dishes with a density of 5.0106 cells. Two days post-transfection,
cells were lysed in 500 µl CoIP buffer (50mM Tris/HCl (pH 8.0),
150mM NaCl, 5mM EDTA, 0.5% NP-40, 1mM PMSF, 2 µg aprotinin
ml 1, 2 µg leupeptin ml 1 and 2 µg pepstatin ml 1). Subsequently, total
lysates were incubated with antibody-coated (2 µl of tag-specific or con-
trol antibodies) Dynabeads® Protein A (30 µl per sample; Life Technol-
ogies) for 2 h at 4

C under rotation. The precipitates were washed five
times with 1ml CoIP buffer. CoIP samples and lysate controls taken
prior to the addition of the CoIP antibody were subjected to standard
Western blot analysis.
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